Acute Respiratory Distress Syndrome (ARDS)
Mayi Hanna Mayi Hanna

Acute Respiratory Distress Syndrome (ARDS)

Acute respiratory distress syndrome (ARDS) is a form of non-cardiogenic respiratory failure caused by widespread inflammation and alveolar–capillary membrane damage. Understanding its pathophysiology, clinical features, and management is essential for recognising severe respiratory deterioration and guiding supportive care.

Read More
INTERSTITIAL LUNG DISEASE: Progressive Restrictive Lung Disorders
Mayi Hanna Mayi Hanna

INTERSTITIAL LUNG DISEASE: Progressive Restrictive Lung Disorders

Interstitial lung disease (ILD) is a group of disorders marked by inflammation and fibrosis of the lung interstitium, leading to stiff, non-compliant lungs and impaired gas exchange. Understanding ILD is important because progressive thickening of the alveolar–capillary membrane increases the work of breathing, causes exertional hypoxaemia, and can ultimately lead to respiratory failure and pulmonary hypertension.

Read More
PULMONARY EMBOLISM
Mayi Hanna Mayi Hanna

PULMONARY EMBOLISM

Pulmonary embolism (PE) is a condition in which a blood clot, usually originating from the deep veins of the legs, lodges in the pulmonary arterial circulation and abruptly obstructs blood flow through the lungs. Understanding PE is critical because it causes both impaired gas exchange and acute right ventricular strain, explaining why it can range from subtle symptoms to sudden cardiovascular collapse and death.

Read More
PNEUMONIA
Mayi Hanna Mayi Hanna

PNEUMONIA

Pneumonia is an acute infection of the lung parenchyma in which inflammation and alveolar exudate impair normal gas exchange. Understanding pneumonia is essential because its physiological effects—alveolar consolidation, ventilation–perfusion mismatch and systemic inflammation—explain hypoxaemia, respiratory distress and the risk of rapid clinical deterioration.

Read More
TYPE 1 VS TYPE 2 RESPIRATORY FAILURE
Mayi Hanna Mayi Hanna

TYPE 1 VS TYPE 2 RESPIRATORY FAILURE

Respiratory failure occurs when the lungs cannot maintain adequate gas exchange and is classified into Type 1 (hypoxaemic) and Type 2 (hypercapnic) based on the primary abnormality. Understanding the distinction is essential because each type reflects a different physiological failure—impaired oxygenation versus impaired ventilation—and guides assessment, monitoring and management decisions.

Read More
PULMONARY OEDEMA: Fluid Accumulation in the Alveoli
Mayi Hanna Mayi Hanna

PULMONARY OEDEMA: Fluid Accumulation in the Alveoli

Pulmonary oedema is a condition in which fluid accumulates in the interstitial and alveolar spaces of the lungs, impairing gas exchange and lung mechanics. Understanding its pathophysiology is essential for distinguishing cardiogenic causes from non-cardiogenic causes and guiding appropriate clinical management.

Read More
PNEUMOTHORAX: Loss of Negative Intrapleural Pressure Leading to Lung Collapse
Mayi Hanna Mayi Hanna

PNEUMOTHORAX: Loss of Negative Intrapleural Pressure Leading to Lung Collapse

Pneumothorax is a condition in which air enters the pleural space, abolishing the negative intrapleural pressure required to keep the lung expanded and leading to partial or complete lung collapse. Understanding this mechanism is essential for recognising how pneumothorax impairs ventilation, why symptoms can progress rapidly, and when the condition becomes life-threatening.

Read More
PLEURAL EFFUSION: Fluid Accumulation in the Pleural
Mayi Hanna Mayi Hanna

PLEURAL EFFUSION: Fluid Accumulation in the Pleural

Pleural effusion is the accumulation of excess fluid within the pleural space, which mechanically restricts lung expansion and interferes with normal ventilation and gas exchange. Understanding pleural effusion is important because the underlying mechanism causing fluid accumulation determines its clinical significance, guiding diagnosis, investigation, and management.

Read More
CYSTIC FIBROSIS
Mayi Hanna Mayi Hanna

CYSTIC FIBROSIS

Cystic fibrosis is an inherited multisystem disorder caused by defective chloride and sodium transport across epithelial surfaces, leading to thick, dehydrated secretions in the airways. Understanding its pathophysiology is important because it explains the persistent airway obstruction, chronic infection and progressive lung damage that drive respiratory failure and long-term outcomes.

Read More
ASTHMA: Chronic Inflammatory Airway Disease With Reversible Airflow Obstruction
Mayi Hanna Mayi Hanna

ASTHMA: Chronic Inflammatory Airway Disease With Reversible Airflow Obstruction

Asthma is a chronic inflammatory airway disease characterised by episodic, reversible airflow obstruction and bronchial hyperresponsiveness. Understanding asthma is important because it explains why symptoms fluctuate, why triggers differ between individuals, and why effective management must target airway inflammation as well as bronchoconstriction.

Read More
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Mayi Hanna Mayi Hanna

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterised by persistent, largely irreversible airflow limitation due to structural damage of the airways and alveoli. Understanding COPD is important because it explains progressive breathlessness, impaired gas exchange, and the long-term respiratory and cardiovascular consequences of chronic exposure to noxious stimuli such as cigarette smoke.

Read More